Tech Company Financing Transactions
Athenix Funding Round
Athenix, operating out of Research Triangle Park, secured $10 million in investment from Covera Ventures, Intersouth Partners and Polaris Partners.
Transaction Overview
Company Name
Announced On
7/22/2008
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
108 T.W. Alexander Dr.
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
Athenix is a leading biotechnology company developing innovative, high-value, bio-industrial products for the Agricultural and Chemical businesses using genetic traits from microbes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Koziel
Chief Financial Officer
Mark Hahn
Chief Operating Officer
Markus Andres
VP - Bus. Development
Scott Uknes
VP - Product Management
Nadine Carozzi
VP - R & D
Nicholas Duck
Browse more venture capital transactions:
Prev: 7/22/2008: TicketLeap.com venture capital transaction
Next: 7/23/2008: DocVerse venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs